ACIs

Related by string. acid * * acid rain . essential fatty acid . fatty acid composition . amino acid sequence . fatty acid metabolism . amino acid sequences . stomach acid . Scratch Acid . amino acid peptide . amino acid residues . concentrated sulfuric acid . concentrated nitric acid . eicosapentaenoic acid EPA . EPA eicosapentaenoic acid . hydrogen sulfide sulfuric acid *

Related by context. Frequent words. (Click for all words.) 62 targeting CD# 61 Azedra 60 ALN VSP 59 HCV protease 59 Allovectin 7 R 59 refractory chronic lymphocytic 59 R sorafenib tablets 59 Neo Urinary Conduit 58 orally bioavailable 58 Tamibarotene 58 gastrointestinal stromal tumors GIST 58 relapsed multiple myeloma 58 liposomal formulation 58 ALN TTR# 58 MOZOBIL 58 Factor VIIa 57 INCB# [001] 57 TLR9 agonist 57 Pivotal Trial 57 humanized anti 57 Sym# 56 otelixizumab 56 Icatibant 56 ISTODAX 56 Fingertip Formulary 56 forodesine 56 humanized antibody 56 therapeutic monoclonal antibodies 56 NeuroVax TM 56 cells hESCs 55 L Annamycin 55 sodium Injection 55 SNALP 55 B CLL 55 DCVax R Brain 55 therapeutic modalities 55 secondary hyperparathyroidism 55 Cetrorelix 55 humanized monoclonal antibody 55 anticancer compound 55 Amigal 55 rEEG 55 Microplasmin 55 Revimmune 54 CD# expressing 54 Hemopurifier 54 engineered tumor antigens 54 immunological diseases 54 CD# antibody [001] 54 molecular biomarkers 54 dependent cellular cytotoxicity 54 proteins peptides 54 Amrubicin 54 investigational mTOR inhibitor 54 ApoB SNALP 53 multipotent 53 HuCNS SC cells 53 factor G CSF 53 anticancer therapies 53 Recombinant Human 53 novel antibody therapeutics 53 investigational compounds 53 adenovector 53 PLX cells 53 multiple myeloma MM 53 HERmark 53 systemic lupus erythematosus SLE 53 custirsen 53 liposomal 53 tumor antigens 53 Veronate 53 SGLT2 53 ZFP Therapeutic 53 AeroLEF R 53 hypoparathyroidism 53 synthetic peptide 53 Alineo 53 TYRX 52 FGFR 52 human parthenogenetic stem 52 human antibody therapeutics 52 Thrombin 52 Chrysalin 52 PEGylated 52 HuCNS SC 52 anemias 52 autologous bone marrow 52 phase IIb clinical 52 hospitals physicians homecare 52 short interfering RNA 52 dacetuzumab 52 glycosylated 52 C1 INH 52 allogeneic stem cell 52 CYCLOSET 52 MEK inhibitor 52 Retisert 51 MORAb 51 multiple simultaneous immunological 51 FLT3 51 AZX#

Back to home page